News Report links Sanofi epilepsy drug with thousands of birth de... Depakine and generics linked with defects including spina bifida.
Views & Analysis Disruptive innovation, integrated care the only way forward,... Peter Guenter, head of Sanofi’s Diabetes & Cardiovascular business, on the future of chronic disease care.
News Sanofi/Regeneron eczema data paves way for year's biggest la... Companies look to take on Pfizer after series of setbacks.
News Neuralink unveils trial linking brain implant to robotic arm Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
